Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

BioCorRx (BICX) Depreciation Expense (2016 - 2025)

BioCorRx (BICX) has disclosed Depreciation Expense for 13 consecutive years, with $6918.0 as the latest value for Q4 2025.

  • Quarterly Depreciation Expense fell 45.56% to $6918.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16286.0 through Dec 2025, down 49.05% year-over-year, with the annual reading at $14915.0 for FY2025, 53.34% down from the prior year.
  • Depreciation Expense hit $6918.0 in Q4 2025 for BioCorRx, up from $1474.0 in the prior quarter.
  • In the past five years, Depreciation Expense ranged from a high of $12708.0 in Q4 2024 to a low of $1474.0 in Q3 2025.
  • Historically, Depreciation Expense has averaged $6396.5 across 5 years, with a median of $6420.0 in 2023.
  • Biggest five-year swings in Depreciation Expense: skyrocketed 97.94% in 2024 and later plummeted 77.04% in 2025.
  • Year by year, Depreciation Expense stood at $6567.0 in 2021, then changed by 0.0% to $6567.0 in 2022, then dropped by 2.24% to $6420.0 in 2023, then surged by 97.94% to $12708.0 in 2024, then plummeted by 45.56% to $6918.0 in 2025.
  • Business Quant data shows Depreciation Expense for BICX at $6918.0 in Q4 2025, $1474.0 in Q3 2025, and $4130.0 in Q2 2025.